What Class of Drug Is Fuzeon? Understanding HIV Fusion Inhibitors
•
5 min read
Fuzeon, with the generic name enfuvirtide, was the first HIV fusion inhibitor approved by the U.S. Food and Drug Administration in 2003, representing a new front in the battle against HIV/AIDS. This injectable drug, a fusion inhibitor, targets an early stage of the viral lifecycle and is reserved for specific, treatment-experienced patients with multidrug-resistant HIV.
